NLM Logo

ESA protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
ESA protocol
Unique ID
C056643
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C056643
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cytarabine
Etoposide
Methylprednisolone
Frequency
1
Note
chemotherapy protocol consisting of etoposide, high-dose methylprednisolone & cytarabine; used in the therapy of lymphomas & Hodgkin's disease
Source
Semin Hematol 1988;25(2 Suppl 2):47
Date of Entry
1988/08/24
Revision Date
2000/11/30
ESA protocol Preferred
page delivered in 0.007s